292 related articles for article (PubMed ID: 36507053)
1. Estimated Kidney Tubular Secretion and Kidney, Cardiovascular, and Mortality Outcomes in CKD: The Systolic Blood Pressure Intervention Trial.
Ascher SB; Shlipak MG; Katz R; Bullen AL; Scherzer R; Hallan SI; Cheung AK; Raphael KL; Estrella MM; Jotwani VK; Seegmiller JC; Ix JH; Garimella PS
Kidney Med; 2022 Dec; 4(12):100546. PubMed ID: 36507053
[TBL] [Abstract][Full Text] [Related]
2. Association of Urinary Dickkopf-3 Levels with Cardiovascular Events and Kidney Disease Progression in Systolic Blood Pressure Intervention Trial.
Peschard VG; Scherzer R; Katz R; Chen TK; Bullen AL; Campos K; Estrella MM; Ix JH; Shlipak MG
Kidney360; 2024 May; 5(5):690-697. PubMed ID: 38472135
[TBL] [Abstract][Full Text] [Related]
3. Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial).
Malhotra R; Katz R; Jotwani V; Agarwal A; Cohen DL; Cushman WC; Ishani A; Killeen AA; Kitzman DW; Oparil S; Papademetriou V; Parikh CR; Raphael KL; Rocco MV; Tamariz LJ; Whelton PK; Wright JT; Shlipak MG; Ix JH
Am J Kidney Dis; 2021 Jul; 78(1):48-56. PubMed ID: 33333147
[TBL] [Abstract][Full Text] [Related]
4. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
5. Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.
Garimella PS; Lee AK; Ambrosius WT; Bhatt U; Cheung AK; Chonchol M; Craven T; Hawfield AT; Jotwani V; Killeen A; Punzi H; Sarnak MJ; Wall BM; Ix JH; Shlipak MG
Eur Heart J; 2019 Nov; 40(42):3486-3493. PubMed ID: 31257404
[TBL] [Abstract][Full Text] [Related]
6. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
[TBL] [Abstract][Full Text] [Related]
7. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Chen Y; Zelnick LR; Huber MP; Wang K; Bansal N; Hoofnagle AN; Paranji RK; Heckbert SR; Weiss NS; Go AS; Hsu CY; Feldman HI; Waikar SS; Mehta RC; Srivastava A; Seliger SL; Lash JP; Porter AC; Raj DS; Kestenbaum BR;
Am J Kidney Dis; 2021 Aug; 78(2):226-235.e1. PubMed ID: 33421453
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants.
Bullen AL; Katz R; Jotwani V; Garimella PS; Lee AK; Estrella MM; Shlipak MG; Ix JH
Am J Kidney Dis; 2021 Sep; 78(3):361-368.e1. PubMed ID: 33857535
[TBL] [Abstract][Full Text] [Related]
9. Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
Jotwani VK; Lee AK; Estrella MM; Katz R; Garimella PS; Malhotra R; Rifkin DE; Ambrosius W; Freedman BI; Cheung AK; Raphael KL; Drawz P; Neyra JA; Oparil S; Punzi H; Shlipak MG; Ix JH;
Am J Nephrol; 2019; 49(5):346-355. PubMed ID: 30939472
[TBL] [Abstract][Full Text] [Related]
10. Markers of Kidney Tubular Secretion and Risk of Adverse Events in SPRINT Participants with CKD.
Bullen AL; Ascher SB; Scherzer R; Garimella PS; Katz R; Hallan SI; Cheung AK; Raphael KL; Estrella MM; Jotwani VK; Malhotra R; Seegmiller JC; Shlipak MG; Ix JH
J Am Soc Nephrol; 2022 Oct; 33(10):1915-1926. PubMed ID: 35973732
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Correa S; Pena-Esparragoza JK; Scovner KM; Waikar SS; Mc Causland FR
Am J Kidney Dis; 2020 Jul; 76(1):32-41. PubMed ID: 31864821
[TBL] [Abstract][Full Text] [Related]
12. Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial.
Turbay-Caballero V; Ricardo AC; Chen J; Missikpode C; Lash JP; Aroca-Martinez G; Musso CG
Kidney Med; 2024 Jul; 6(7):100845. PubMed ID: 38966681
[TBL] [Abstract][Full Text] [Related]
13. Association of the Urine-to-Plasma Urea Ratio With CKD Progression.
Liu J; Bankir L; Verma A; Waikar SS; Palsson R
Am J Kidney Dis; 2023 Apr; 81(4):394-405. PubMed ID: 36356680
[TBL] [Abstract][Full Text] [Related]
14. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.
Steubl D; Schneider MP; Meiselbach H; Nadal J; Schmid MC; Saritas T; Krane V; Sommerer C; Baid-Agrawal S; Voelkl J; Kotsis F; Köttgen A; Eckardt KU; Scherberich JE;
Clin J Am Soc Nephrol; 2020 May; 15(5):616-624. PubMed ID: 32291270
[TBL] [Abstract][Full Text] [Related]
15. The kidney and cardiovascular outcome trials.
Bloomgarden Z
J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
[TBL] [Abstract][Full Text] [Related]
16. Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT.
Ascher SB; Berry JD; Katz R; de Lemos JA; Bansal N; Garimella PS; Hallan SI; Wettersten N; Jotwani VK; Killeen AA; Ix JH; Shlipak MG
Am J Kidney Dis; 2024 May; 83(5):615-623.e1. PubMed ID: 37992982
[TBL] [Abstract][Full Text] [Related]
17. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
[TBL] [Abstract][Full Text] [Related]
18. Ultraprocessed Foods and Kidney Disease Progression, Mortality, and Cardiovascular Disease Risk in the CRIC Study.
Sullivan VK; Appel LJ; Anderson CAM; Kim H; Unruh ML; Lash JP; Trego M; Sondheimer J; Dobre M; Pradhan N; Rao PS; Chen J; He J; Rebholz CM;
Am J Kidney Dis; 2023 Aug; 82(2):202-212. PubMed ID: 37028638
[TBL] [Abstract][Full Text] [Related]
19. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
